611 related articles for article (PubMed ID: 16456024)
1. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
[TBL] [Abstract][Full Text] [Related]
2. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
[TBL] [Abstract][Full Text] [Related]
3. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.
Danese S; de la Motte C; Sturm A; Vogel JD; West GA; Strong SA; Katz JA; Fiocchi C
Gastroenterology; 2003 May; 124(5):1249-64. PubMed ID: 12730866
[TBL] [Abstract][Full Text] [Related]
4. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.
Rutella S; Vetrano S; Correale C; Graziani C; Sturm A; Spinelli A; De Cristofaro R; Repici A; Malesci A; Danese S
J Cell Mol Med; 2011 Mar; 15(3):625-34. PubMed ID: 20158572
[TBL] [Abstract][Full Text] [Related]
5. The CD40/CD40L system regulates rat cerebral microvasculature after focal ischemia/reperfusion via the mTOR/S6K signaling pathway.
Jiang RH; Xu XQ; Wu CJ; Lu SS; Zu QQ; Zhao LB; Liu S; Shi HB
Neurol Res; 2018 Sep; 40(9):717-723. PubMed ID: 29843579
[TBL] [Abstract][Full Text] [Related]
6. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration.
Vogel JD; West GA; Danese S; De La Motte C; Phillips MH; Strong SA; Willis J; Fiocchi C
Gastroenterology; 2004 Jan; 126(1):63-80. PubMed ID: 14699489
[TBL] [Abstract][Full Text] [Related]
7. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets.
Anka Idrissi D; Senhaji N; Aouiss A; Khalki L; Tijani Y; Zaid N; Marhoume FZ; Naya A; Oudghiri M; Kabine M; Zaid Y
Arch Pharm Res; 2021 Jan; 44(1):117-132. PubMed ID: 33394309
[TBL] [Abstract][Full Text] [Related]
8. Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.
Di Sabatino A; Ciccocioppo R; Cinque B; Millimaggi D; Morera R; Ricevuti L; Cifone MG; Corazza GR
Gut; 2004 Jan; 53(1):70-7. PubMed ID: 14684579
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
Biancheri P; Di Sabatino A; Rovedatti L; Giuffrida P; Calarota SA; Vetrano S; Vidali F; Pasini A; Danese S; Corazza GR; MacDonald TT
Inflamm Bowel Dis; 2013 Feb; 19(2):259-64. PubMed ID: 23328772
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease.
Danese S; Scaldaferri F; Vetrano S; Stefanelli T; Graziani C; Repici A; Ricci R; Straface G; Sgambato A; Malesci A; Fiocchi C; Rutella S
Gut; 2007 Sep; 56(9):1248-56. PubMed ID: 17317789
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
[TBL] [Abstract][Full Text] [Related]
13. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
Van den Brande JM; Braat H; van den Brink GR; Versteeg HH; Bauer CA; Hoedemaeker I; van Montfrans C; Hommes DW; Peppelenbosch MP; van Deventer SJ
Gastroenterology; 2003 Jun; 124(7):1774-85. PubMed ID: 12806611
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.
Baert FJ; D'Haens GR; Peeters M; Hiele MI; Schaible TF; Shealy D; Geboes K; Rutgeerts PJ
Gastroenterology; 1999 Jan; 116(1):22-8. PubMed ID: 9869598
[TBL] [Abstract][Full Text] [Related]
15. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria.
Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P
Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.
Di Sabatino A; Santilli F; Guerci M; Simeone P; Ardizzone S; Massari A; Giuffrida P; Tripaldi R; Malara A; Liani R; Gurini E; Aronico N; Balduini A; Corazza GR; Davì G
Thromb Haemost; 2016 Aug; 116(3):486-95. PubMed ID: 27305860
[TBL] [Abstract][Full Text] [Related]
17. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
[TBL] [Abstract][Full Text] [Related]
18. CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium.
Omari KM; Dorovini-Zis K
J Neuroimmunol; 2003 Jan; 134(1-2):166-78. PubMed ID: 12507785
[TBL] [Abstract][Full Text] [Related]
19. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
Agnholt J; Kaltoft K
Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
[TBL] [Abstract][Full Text] [Related]
20. Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor.
Kalinichenko TV; Mokyr MB
Cancer Immunol Immunother; 1998 Aug; 46(6):293-303. PubMed ID: 9756413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
